newsfilter
← Latest News
Business Wire·

ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics

ScionxBio (the "company", operating as a brand identity of Eleven Therapeutics Ltd. following a horizontal split) a privately held, preclinical-stage biotechnology company pioneering next-generation mRNA